Showing 5 of 5 recruiting trials for “HIV-associated cancer”
Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)
👨⚕️ Ramya M Ramaswami, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Apr 2026View details ↗
Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
👨⚕️ Ramya M Ramaswami, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Dec 2021View details ↗
Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
👨⚕️ Ramya M Ramaswami, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Sep 2021View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →